Health News Summary: J&J To Seek US FDA Clearance For Booster Injection This Week – NYT; US CDC advises against travel to Austria, Barbados due to COVID-19 and more
Here is a summary of the current health briefs.
Henrietta Lacks estate claims drug company took advantage of stolen cells
The estate of a black woman whose cervical cells were taken from her decades ago without her permission sued a pharmaceutical company on Monday, claiming she made a “conscious choice” to mass produce the cells and profit. of a “racially unjust medical system”. The estate of Henrietta Lacks did not “see a dime” of the income Thermo Fisher Scientific generated by cultivating the HeLa cell line that was taken from Lacks at Johns Hopkins Hospital in 1951, according to the lawsuit filed before the Maryland Federal Court.
Factbox-Countries assess need for COVID-19 booster doses
Many countries are preparing to make booster shots of the COVID-19 vaccine available, but scientists disagree that they are necessary and the World Health Organization wants those most vulnerable in the world. the world are fully immunized first. The following describes some of the options that countries and regions are considering on the issue:
One year after proposed COVID vaccine waiver, WTO negotiations stalled
A year after South Africa and India presented a new proposal https://www.reuters.com/article/us-health-coronavirus-wto/india-and-south-africa-ask-wto- to-waive-rules-to -aid-covid-19-drug-production-idUSKBN26P0H1 to temporarily waive intellectual property rights to COVID-19 vaccines and therapies at the World Trade Organization, negotiations are deadlocked and without direction, business sources said Monday after a meeting on the matter. More than 100 countries supporting the waiver say it will help save lives by enabling developing countries to produce COVID-19 vaccines. But a handful of countries, some of which host large pharmaceutical companies like Switzerland, remain against it. Washington supported the proposal https://www.reuters.com/business/healthcare-pharmaceuticals/us-trade-chief-says-wto-vaccine-talks-should-remove-obstacles-production-2021-05-12 in May , sparking the expectation of a breakthrough that has yet to materialize.
J&J to seek US FDA clearance for booster injection this week – NYT
Johnson & Johnson plans to ask U.S. federal regulators this week to authorize a booster of its COVID-19 vaccine, The New York Times reported https://www.nytimes.com/live/2021/10/04/world/ covid -delta-variant-vaccine # johnson-johnson-will-seek-fda-authorization-for-a-booster-shot on Monday, citing officials familiar with the company’s plans. As scientists are divided over the need for booster vaccines as so many people in the United States and other countries go unvaccinated, the Biden administration announced the push for an additional dose in August as part of the an effort to strengthen protection against the highly transmissible delta. variant.
Drugstore chains failed to prevent opioid abuse, US jury says
Drugstore operators, including CVS Health Corp and Walmart Inc, have fueled the opioid epidemic in the United States by failing to prevent massive amounts of addictive pain relievers from reaching the black market, an attorney for the United States said Monday. two Ohio counties at the start of a lawsuit. Mark Lanier told a federal jury in Cleveland during the hearing of the first trial that drugstore chains faced in a nationwide litigation over the epidemic that companies were responsible for drug abuse in the counties of Lake and Trumbull.
Exclusive-Eli Lilly’s recalled emergency diabetes drug comes from plant cited by FDA
A recently recalled batch of glucagon emergency kits, Eli Lilly and Co’s therapy for diabetic patients in crisis, was manufactured at an Indiana plant cited by US health regulators this year for violations of quality control, including several involving this product, according to the company; and a Reuters review of federal inspection records. The Indianapolis-based company on September 24 issued a voluntary recall in the United States of a batch of kits whose key ingredient is Glucagon, a drug used to treat dangerously low blood sugar in diabetic patients. The company issued a voluntary recall in Canada the next day.
Two Americans win Nobel Prize in medicine for their work on heat and touch
US scientists David Julius and Ardem Patapoutian won the 2021 Nobel Prize in Medicine on Monday for the discovery of receptors in the skin that sense temperature and touch and could pave the way for new pain relievers. Their work, conducted independently, has helped show how humans convert the physical impact of heat or touch into nerve impulses that allow us to “perceive and adapt to the world around us,” said L Nobel Assembly of the Karolinska Institute in Sweden.
US CDC advises against travel to Austria and Barbados due to COVID-19
The U.S. Centers for Disease Control and Prevention (CDC) on Monday warned against travel to Armenia, Austria, Barbados, Croatia and Latvia over concerns over COVID-19. The CDC raised its travel recommendations to “Level 4: Very High,” telling Americans they should avoid travel to all five countries.
US administers nearly 397 million doses of COVID-19 vaccine – CDC
The United States had administered 396,919,564 doses of COVID-19 vaccines nationwide as of Monday morning and distributed 478,392,765 doses, the United States Centers for Disease Control and Prevention said. Those numbers were up from the 395,934,825 doses of the vaccine that the CDC said had taken to arms on Sunday.
EU regulator supports recall of mRNA vaccine for people with low immunity
The European Union’s medicines regulator said on Monday that people with weakened immune systems should receive a third dose of a COVID-19 vaccine from Pfizer-BioNTech or Moderna, but left it up to member states to decide. so the population at large should have a booster. The long-awaited directives come after several EU member states anticipated the opinion of the European Medicines Agency (EMA) and launched their own recall campaigns, although they vary widely in who is eligible.
(With contributions from agencies.)